NanoViricides is trading 8.5% up at $1.61 as the stock extends a recent rebound from late-July lows despite a lack of fresh company-specific news or analyst actions.
- The move appears driven by continued momentum in the thinly traded micro-cap, supported by a broadly positive U.S. equity backdrop.
- Major indexes are trading modestly higher this morning, providing a favorable environment for small-cap stocks.
- No new regulatory filings or corporate developments have been reported to account for the current price action.